Cencora, Inc. has revised its historical financial reporting from its fiscal 2025 annual report to align with a new segment structure taking effect in fiscal 2026. This reorganization divides the company into U.S. Healthcare Solutions, International Healthcare Solutions, and an “Other” category for businesses under strategic review. The informational Form 8-K filing updates segment disclosures for investors, without altering audited 2025 financial statements.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Cencora Updates Segment Reporting Following Strategic Business Review
Cencora, Inc. has revised its historical financial reporting from its fiscal 2025 annual report to align with a new segment structure taking effect in fiscal 2026. This reorganization divides the company into U.S. Healthcare Solutions, International Healthcare Solutions, and an “Other” category for businesses under strategic review. The informational Form 8-K filing updates segment disclosures for investors, without altering audited 2025 financial statements.